ArticleOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde2026
One-Month versus 3-Month Heavy Silicone Oil Tamponade in Complex Rhegmatogenous Retinal Redetachment.
Article in Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of the study was to compare functional and anatomical results after 1- vs. 3-month heavy silicone oil (HSO) tamponade to repair complex inferior recurrent rhegmatogenous retinal detachment (Re-RRD).
methodsA retrospective, comparative, cohort study was conducted involving 46 eyes from 46 patients who were affected by complex inferior Re-RRD and had previously undergone tamponade with either gas or silicone oil. All the eyes were treated using HSO (Densiron® 68), which was removed after 1 (group A) or 3 months (group B). The outcomes included the attachment rate, best-corrected visual acuity (BCVA), and intraocular pressure (IOP), comparing these results at 3, 6, and 12 months after HSO removal.
resultsOut of 46 eyes that experienced a complex inferior Re-RRD after initial surgery and received HSO, 24 were in group A and 22 in group B, with HSO removal after 1 and 3 months, respectively. The reattachment rates were similar: 91.6% for group A and 81.8% for group B (p = 0.4). In group A, a significant visual gain occurred during all follow-up (p < 0.001); in group B, the significant improvement (p ≤ 0.03) was lost at 12 months. Mean BCVA was better in group A than B at 6 and 12 months (p ≤ 0.02). Group B exhibited a significant increase in mean IOP after 3 months (p < 0.001), consistently exceeding the values observed in group A throughout the follow-up (p ≤ 0.002). Macular edema occurred in 7 eyes, with no notable differences between the groups.
conclusionA 1-month HSO endotamponade has a similar reattachment rate but provides better visual recovery and controlled IOP than a 3-month endotamponade in complex Re-RRD with inferior involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.